Taygan Yilmaz

Summary

Publications

  1. doi Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review
    Taygan Yilmaz
    Harvard Vanguard Medical Associates, Department of Visual Services, 133 Brookline Avenue, Boston, MA 02215, USA
    Graefes Arch Clin Exp Ophthalmol 250:787-93. 2012
  2. pmc Ketorolac therapy for the prevention of acute pseudophakic cystoid macular edema: a systematic review
    T Yilmaz
    Department of Ophthalmology, Stony Brook University, NY 11733, USA
    Eye (Lond) 26:252-8. 2012
  3. doi Pharmacokinetics of triamcinolone acetonide for the treatment of macular edema
    Taygan Yilmaz
    Stony Brook University, Department of Ophthalmology, 33 Research Way, East Setauket, NY 11733, USA
    Expert Opin Drug Metab Toxicol 7:1327-35. 2011
  4. doi Systematic review of intravitreal bevacizumab injection for treatment of primary diabetic macular oedema
    Taygan Yilmaz
    Department of Preventive Medicine, Stony Brook University, Stony Brook, NY 11794, USA
    Acta Ophthalmol 89:709-17. 2011
  5. doi Pars plana vitrectomy versus immunomodulatory therapy for intermediate uveitis: a prospective, randomized pilot study
    Karina Quinones
    Massachusetts Eye Research and Surgery Institution, Cambridge, MA, USA
    Ocul Immunol Inflamm 18:411-7. 2010
  6. ncbi Intravitreal bevacizumab in refractory uveitic macular edema: one-year follow-up
    Rene A Cervantes-Castaneda
    Massachusetts Eye Research and Surgery Institution, Cambridge, MA, USA
    Eur J Ophthalmol 19:622-9. 2009

Collaborators

Detail Information

Publications6

  1. doi Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review
    Taygan Yilmaz
    Harvard Vanguard Medical Associates, Department of Visual Services, 133 Brookline Avenue, Boston, MA 02215, USA
    Graefes Arch Clin Exp Ophthalmol 250:787-93. 2012
    ....
  2. pmc Ketorolac therapy for the prevention of acute pseudophakic cystoid macular edema: a systematic review
    T Yilmaz
    Department of Ophthalmology, Stony Brook University, NY 11733, USA
    Eye (Lond) 26:252-8. 2012
    ..These results, however, should be interpreted with caution considering the paucity of large randomized clinical trials in the literature...
  3. doi Pharmacokinetics of triamcinolone acetonide for the treatment of macular edema
    Taygan Yilmaz
    Stony Brook University, Department of Ophthalmology, 33 Research Way, East Setauket, NY 11733, USA
    Expert Opin Drug Metab Toxicol 7:1327-35. 2011
    ..This has led to the need for repeated injections. Future research should investigate the pharmacokinetic profiles of TA when administered intravitreally, as well as through alternate routes in more robust studies...
  4. doi Systematic review of intravitreal bevacizumab injection for treatment of primary diabetic macular oedema
    Taygan Yilmaz
    Department of Preventive Medicine, Stony Brook University, Stony Brook, NY 11794, USA
    Acta Ophthalmol 89:709-17. 2011
    ....
  5. doi Pars plana vitrectomy versus immunomodulatory therapy for intermediate uveitis: a prospective, randomized pilot study
    Karina Quinones
    Massachusetts Eye Research and Surgery Institution, Cambridge, MA, USA
    Ocul Immunol Inflamm 18:411-7. 2010
    ..Comparison of pars plana vitrectomy (PPV) with immunomodulatory therapy (IMT) for patients with intermediate uveitis (IU)...
  6. ncbi Intravitreal bevacizumab in refractory uveitic macular edema: one-year follow-up
    Rene A Cervantes-Castaneda
    Massachusetts Eye Research and Surgery Institution, Cambridge, MA, USA
    Eur J Ophthalmol 19:622-9. 2009
    ..In this article, we evaluate the long-term outcome of intravitreal bevacizumab in the treatment of refractory uveitic macular edema...